TY  - CHAP
AU  - Sepideh Heydarkhan-Hagvall
AU  - Ali Nsair
AU  - Ramin E. Beygui
AU  - Richard J. Shemin
ED  - Daniel Eberli
Y1  - 2010-03-01
PY  - 2010
T1  - The Future of Cell Therapy and Tissue Engineering in Cardiovascular Disease: The New Era of Biological Therapeutics
N2  - The Tissue Engineering approach has major advantages over traditional organ transplantation and circumvents the problem of organ shortage. Tissues that closely match the patient’s needs can be reconstructed from readily available biopsies and subsequently be implanted with minimal or no immunogenicity. This eventually conquers several limitations encountered in tissue transplantation approaches.
This book serves as a good starting point for anyone interested in the application of Tissue Engineering. It offers a colorful mix of topics, which explain the obstacles and possible solutions for TE applications.
BT  - Tissue Engineering
SP  - Ch. 2
UR  - https://doi.org/10.5772/8589
DO  - 10.5772/8589
SN  - 
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-19
ER  -